Conflict of interest statement: HS received educational research grants from Novartis Japan Oncology and Pfizer Japan Oncology. YM received educational research grants from Pfizer Japan. The other authors disclosed no potential conflicts of interest.
Aromatase inhibitor treatment of breast cancer cells increases the expression of let-7f, a microRNA targeting CYP19A1†
Version of Record online: 30 APR 2012
Copyright © 2012 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
The Journal of Pathology
Volume 227, Issue 3, pages 357–366, July 2012
How to Cite
Shibahara, Y., Miki, Y., Onodera, Y., Hata, S., Chan, M. S., Yiu, C. C., Loo, T. Y., Nakamura, Y., Akahira, J.-i., Ishida, T., Abe, K., Hirakawa, H., Chow, L. W., Suzuki, T., Ouchi, N. and Sasano, H. (2012), Aromatase inhibitor treatment of breast cancer cells increases the expression of let-7f, a microRNA targeting CYP19A1. J. Pathol., 227: 357–366. doi: 10.1002/path.4019
- Issue online: 6 JUN 2012
- Version of Record online: 30 APR 2012
- Accepted manuscript online: 9 MAR 2012 10:02AM EST
- Manuscript Accepted: 21 FEB 2012
- Manuscript Revised: 7 FEB 2012
- Manuscript Received: 24 OCT 2011
|path_4019_sm_suppinfofs1.tif||57K||Supporting Information: Figure S1. Ki-67 proliferation index (%) of pre-AI and post-AI treatment in the patients.|
|path_4019_sm_suppinfo.doc||22K||Supporting Information: Legend to Figure S1|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.